STAT

Polio eradication initiative meets resistance to appeals to destroy samples

For more than two years, the global initiative to eradicate polio has been trying to convince companies and laboratories to get rid of stored samples of an extinct poliovirus. There…
Source: Sean Gallup/Getty Images

For more than two years, the global initiative to eradicate polio has been trying to convince companies and laboratories around the world to get rid of stored samples of an extinct poliovirus, with little success.

Thirty countries have indicated they plan to hold on to type 2 polioviruses, in a total of 99 facilities. That, health officials warn, could endanger years of efforts to stop the virus from crippling children.

“I think it’s more than what was anticipated,” said Dr. David Heymann, an infectious diseases expert who formerly ran the polio program at the World Health Organization and who currently

You’re reading a preview, subscribe to read more.

More from STAT

STAT2 min read
STAT+: Pharmalittle: We’re Reading About Cigna Biosimilar Plans, A Vertex Deal In South Africa, And More
Cigna plans to make copies of AbbVie's Humira arthritis drug available with no out-of-pocket payment to eligible patients in the U.S.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About CVS And Humira Biosimilars, Schumer’s Broken Insulin Promise, And More
New prescriptions for biosimilar versions of Humira, one of the best-selling drugs in the U.S., surged to 36% from just 5% during the first week of April.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About Biocon Eyeing Weight Loss Drugs, Sanofi Layoffs, And More
Biocon is pivoting to weight loss drugs as patents for the blockbuster medicines start to expire, unleashing a coming wave of generics.

Related Books & Audiobooks